The integrity of the plasma membrane is maintained through an active repair process, especially in skeletal and cardiac muscle cells, in which contraction-induced mechanical damage frequently occurs in vivo 1,2 . Muscular dystrophies (MDs) are a group of muscle diseases characterized by skeletal muscle wasting and weakness 3, 4 . An important cause of these group of diseases is defective repair of sarcolemmal injuries, which normally requires Ca 2+ sensor proteins [5] [6] [7] [8] and Ca 2+ -dependent delivery of intracellular vesicles to the sites of injury 8, 9 . MCOLN1 (also known as TRPML1, ML1) is an endosomal and lysosomal Ca 2+ channel whose human mutations cause mucolipidosis IV (ML4), a neurodegenerative disease with motor disabilities 10,11 . Here we report that ML1-null mice develop a primary, early-onset MD independent of neural degeneration. Although the dystrophin-glycoprotein complex and the known membrane repair proteins are expressed normally, membrane resealing was defective in ML1-null muscle fibers and also upon acute and pharmacological inhibition of ML1 channel activity or vesicular Ca 2+ release. Injury facilitated the trafficking and exocytosis of vesicles by upmodulating ML1 channel activity. In the dystrophic mdx mouse model, overexpression of ML1 decreased muscle pathology. Collectively, our data have identified an intracellular Ca 2+ channel that regulates membrane repair in skeletal muscle via Ca 2+ -dependent vesicle exocytosis.
The integrity of the plasma membrane is maintained through an active repair process, especially in skeletal and cardiac muscle cells, in which contraction-induced mechanical damage frequently occurs in vivo 1, 2 . Muscular dystrophies (MDs) are a group of muscle diseases characterized by skeletal muscle wasting and weakness 3, 4 . An important cause of these group of diseases is defective repair of sarcolemmal injuries, which normally requires Ca 2+ sensor proteins [5] [6] [7] [8] and Ca 2+ -dependent delivery of intracellular vesicles to the sites of injury 8, 9 . MCOLN1 (also known as TRPML1, ML1) is an endosomal and lysosomal Ca 2+ channel whose human mutations cause mucolipidosis IV (ML4), a neurodegenerative disease with motor disabilities 10, 11 . Here we report that ML1-null mice develop a primary, early-onset MD independent of neural degeneration. Although the dystrophin-glycoprotein complex and the known membrane repair proteins are expressed normally, membrane resealing was defective in ML1-null muscle fibers and also upon acute and pharmacological inhibition of ML1 channel activity or vesicular Ca 2+ release. Injury facilitated the trafficking and exocytosis of vesicles by upmodulating ML1 channel activity. In the dystrophic mdx mouse model, overexpression of ML1 decreased muscle pathology. Collectively, our data have identified an intracellular Ca 2+ channel that regulates membrane repair in skeletal muscle via Ca 2+ -dependent vesicle exocytosis.
We used PCR genotyping to confirm in our targeted mouse strain the presence of a genetic deletion of Mcoln1 (referred to as ML1 KO) 11 (Supplementary Fig. 1a ; see Supplementary Data Set). Using reverse transcription PCR (RT-PCR), we detected no full-length ML1 transcript in skeletal muscle and cultured myoblasts isolated from ML1 KO mice (Fig. 1a) . Consistent with these results, patchclamping of the endolysosomal membranes 12 showed that ML1-like currents (I ML1 ) were activated in whole endolysosomes by ML-SA1, a membrane-permeable ML1-specific synthetic agonist 13 , in wildtype (WT) but not ML1 KO primary cultured myoblasts (Fig. 1b) . I ML1 was potently inhibited by ML-SI compounds (Fig. 1b) , which are membrane-permeable ML-specific synthetic inhibitors 14 .
At 1 month of age, ML1 KO mice are grossly healthy and do not show any obvious neurodegeneration 11 . However, when they are challenged with a 15° downhill treadmill test at the speed of 20 m/min, ML1 KO mice show a pronounced defect in their motor functions and a greatly reduced ability to remain on the treadmill (Fig. 1c) . Histological analysis of various tissues involved in the movement impairment revealed, unexpectedly, that the skeletal muscles of ML1 KO mice had clear signs of dystrophy, even at 1 month of age (Fig. 1d,e) . Indeed, by this early age, we detected individual necrotic and centrally nucleated fibers in ML1 KO skeletal muscle (Fig. 1d,e) . In contrast, there was no obvious dystrophy in WT skeletal muscle at any age examined (Fig. 1e,f) .
By 3 months of age, we commonly found central nucleation, fibrosis (fibrous scar tissue and fat replacement) and immune cell infiltration (Fig. 1d,e and Supplementary Fig. 1 ) in the skeletal muscles of ML1 KO mice. As observed in most animal models of MD 15 , the distribution of the dystrophic area in skeletal muscle was heterogeneous. For example, for the gastrocnemius muscle, the dystrophic area was mainly concentrated on the periphery of the muscle and the central region remained largely intact (Fig. 1d) . A characteristic of MD is muscle regeneration triggered by degeneration, forming a cycle of degeneration and regeneration 4, 9 . Hence, centrally nucleated muscle fibers and smaller-sized fibers are frequently observed, reflecting muscles undergoing active regeneration 4, 9 . Consistent with this finding, ML1 KO fibers were relatively small, with a high degree of central nucleation (Fig. 1d,g,h) .
ML1 KO mice exhibited progressive MD, with severity increasing with age ( Fig. 1e-g ). Muscle-specific heterogeneity is common in patients with MD, potentially resulting from the variability in usedependent physical activity of different muscles 3, 4 . In 1-month-old
The intracellular Ca 2+ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy l e t t e r s 1 1 8 8 VOLUME 20 | NUMBER 10 | OCTOBER 2014 nature medicine ML1 KO mice, only about half of the skeletal muscles, including the triceps, quadriceps, hamstring and gastrocnemius muscles, manifested dystrophy (Supplementary Fig. 1c ). In contrast, the diaphragm, iliopsoas, gluteus, soleus and tibialis anterior muscles appeared normal (Supplementary Fig. 1c) . However, by 3 months of age, more skeletal muscles developed dystrophy ( Supplementary  Fig. 1d ). Both type 1 slow-twitch and type 2 fast-twitch muscle fibers were dystrophic (Supplementary Fig. 2a ). However, cardiac and smooth muscles in 3-month-old ML1 KO mice did not show obvious pathology (Supplementary Fig. 2b ). These results suggest that ML1 KO mice exhibited early-onset, progressive and extensive MD. Evans blue (EB) dye is a reliable in vivo marker of myofiber damage 16 . A small but significant percentage of ML1 KO gastrocnemius myofibers were EB positive at rest (Fig. 2a,b) . After a 15° downhill treadmill exercise, the percentage of EB-positive cells in the ML1 KO gastrocnemius muscle increased from 2% to 12% (Fig. 2a,b) . In comparison, the percentage of EB-positive cells in WT littermates never exceeded 1%, even after treadmill exercise (Fig. 2a,b) .
Another measure of myofiber damage is the leakage of muscle proteins into the serum 3, 4 . Consistent with the EB analysis, the serum creatine kinase (CK) levels of ML1 KO mice were twofold to three-fold higher than those of their WT littermates (Fig. 2c) . Treadmill exercise increased serum CK levels further (Fig. 2c) . These results suggest that an increase in muscle membrane damage underlies MD in ML1 KO mice.
Although muscle pathology and elevated CK levels were initially reported in some ML4 patients 17, 18 , ML4 has generally been considered a disease of neural degeneration 10, 11 , which could explain the motor defects of ML4 patients and ML1 KO mice. Consistent with previous reports 11, 19 , ML1 KO mice did exhibit neuronal cell death, but only at ages >5 months (Supplementary Fig. 2c ). At younger ages (1-3 months), motor neurons in the spinal cord did not show any obvious sign of neural degeneration ( Supplementary  Fig. 2d ). Likewise, sciatic nerve myelination was normal in ML1 KO mice at 1 month of age (Fig. 2d) . Furthermore, in conditions mimicking neural degeneration, such as sciatic nerve axotomy, we did not observe a dystrophic phenotype (Fig. 2e) . Instead, axotomy resulted in muscle atrophy, which manifested as a homogeneous decrease in fiber size (Fig. 2e) . In addition, gastrocnemius muscle from the mouse model of Fabry's disease 20 showed denervation-like effects on the fiber size but not MD-like necrosis or central nucleation (Fig. 2f) . In 1-month-old ML1 KO mice, we saw only minimal evidence of lysosomal storage disease (LSD) in the dystrophic muscles (Supplementary Fig. 2e ). These results suggest that muscle dystrophy in the ML1 KO mice is unlikely to be a secondary effect of neural degeneration or a lysosome storage defect. 
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To investigate directly the dystrophic mechanisms caused by ML1 deficiency, we performed a rescue experiment involving intramuscular injection of an adeno-associated virus (AAV) carrying the GFP-ML1 transgene (AAV-GFP-ML1), which typically infected most (>85%) of the muscle fibers. As observed in many lysosomal storage disorders (LSDs), ML1 KO muscle showed a compensatory increase in the key lysosomal protein Lamp1 (ref. 13) , as indicated by Lamp1 immunofluorescence staining and western blot analysis (Supplementary Fig. 3a,b) . However, when compared with the uninfected adjacent and contralateral muscle fibers, ML1 KO gastrocnemius muscle infected with AAV-GFP-ML1 (localized in Lamp1-positive compartments; Supplementary Fig. 3c,d) showed a strong AAV infection−mediated decrease of elevated Lamp1 expression ( Fig. 2g and Supplementary  Fig. 3e ). AAV-ML1-GFP infection reduced the dystrophic area (Fig. 2h) and collagen content (Fig. 2i) of the muscle as well as the percentage of EB-positive muscle fibers (Fig. 2j) . Hence, expression of ML1 in muscle was sufficient to rescue the MD of ML1 KO mice, suggesting a cell-autonomous mechanism as the underlying cause of MD in these mice.
Mechanical stress can cause myofiber necrosis by two separate mechanisms. First, the sarcolemma of a muscle fiber could be more susceptible to damage, as seen in dystrophin (a core component of the dystrophin-glycoprotein complex (DGC)) mutant (mdx) mice 4, 21 . Second, a muscle fiber could have a defect in sarcolemma repair, as seen in dysferlin or MG53 knockout mice 5, 9, 22 . Most human MD mutations are linked to defects in the components of the DGC 4 . However, we saw no obvious decrease in expression of any of the core or accessory components of the DGC that we examined, which included dystrophin, β-dystroglycan (β-DG), integrin β1 and laminin (Fig. 3a,b) . Furthermore, the expression of dysferlin, caveolin 3 and MG53, three proteins known to be involved in sarcolemma repair and human MD 4, 5, 23 , also showed no decrease in ML1 KO muscle (Fig. 3a,b) .
To create plasma membrane disruptions and to evaluate the resealing efficiency, we irradiated single myofibers isolated from the flexor digitorum brevis (FDB) muscle of WT and ML1 KO mice using a two-photon laser 5, 9 . FM1-43, a membrane-impermeable fluorescent dye that preferentially adheres to lipids, is commonly used to detect membrane disruptions 5 . We observed rapid entry and accumulation npg of FM1-43 dye within seconds after laser irradiation ( Fig. 3c and Supplementary Fig. 4a ). However, in WT muscle fibers, dye entry ceased shortly (1-2 min) after irradiation, suggesting successful membrane resealing (Fig. 3c) . In contrast, upon identical laser irritation of fibers from ML1 KO mice, uptake of the FM1-43 dye continued at the injury sites for several minutes (Fig. 3c) , suggesting failed membrane resealing. Removal of extracellular Ca 2+ caused rapid accumulation of FM1-43 dye at the injury sites, which was indistinguishable for myofibers from WT and ML1 KO mice ( Supplementary  Fig. 4b ). We also observed defective membrane resealing in myotubes from ML1 KO mice that were exposed to mechanical damage elicited by microelectrode penetration into the sarcolemmal membrane (Fig. 3d) . Unlike most myotubes from WT mice, most (>80%) of those from ML1 KO mice could not 'survive' the prolonged contractions caused by continuous Ca 2+ entry.
Next, we performed pharmacological experiments on myotubes derived from the C2C12 mouse cell line using the microelectrode penetration assay 24 . We did not see substantial uptake of FM4-64 dye (a red-colored analog of the FM1-43 dye) at injury sites, even with repeated penetrations (Fig. 3e) . In contrast, removal of extracellular Ca 2+ substantially increased the entry of FM dyes ( Supplementary  Fig. 4c) , suggesting that the influx of extracellular Ca 2+ is essential for repair 8 . In the presence of BAPTA-AM, used to chelate intracellular Ca 2+ , or glycyl-l-phenylalanine 2-naphthylamide (GPN), a lysosometargeted cathepsin C substrate, to specifically deplete the lysosomal Ca 2+ store 13 , we observed substantial dye entry even under normal extracellular Ca 2+ concentrations (2 mM; Fig. 3e) . These results suggest that lysosomal Ca 2+ also has a role in membrane resealing.
To monitor the Ca 2+ levels at injury sites, we transfected myoblasts from WT and ML1 KO mice and C2C12 cells with Lamp1-GCaMP3, The effect of ML-SI3, a MLspecific synthetic inhibitor, on EB dye uptake in WT gastrocnemius muscles injected with the cardiotoxin VII4 (CTX), a cytolytic toxin that disrupts cell membrane in living animals 24 . Right, effect of intramuscular co-injection of ML-SI3 with CTX on EB dye uptake in muscle from WT and ML1 KO mice (n = 3 animals for each condition). Images are representative of overall 15 sections from 3 experiments. Scale bar, 10 µm. Data are presented as the mean ± s.e.m. *P < 0.05. npg a lysosome-targeted genetically encoded Ca 2+ indicator 13 . We observed transient Ca 2+ increases at injury sites in the presence or absence of external Ca 2+ (Supplementary Fig. 4d−g ). However, release of intracellular Ca 2+ was less in myoblasts from ML1 KO mice or in the presence of ML-SI compounds 14 ( Supplementary Fig. 4f,g ), suggesting a contribution to Ca 2+ release from lysosomes during membrane damage or the early stage of membrane repair. In the presence of external Ca 2+ , we observed a prolonged Ca 2+ influx in myoblasts from ML1 KO mice or ML-SI3-treated C2C12 myoblasts ( Supplementary  Fig. 4d,e) . Hence, ML1 has a dual role in promoting the initial phase of Ca 2+ increase (within seconds) but inhibiting the prolonged phase of Ca 2+ increase (lasting minutes). To test whether ML1 has a direct role in membrane repair, we acutely inhibited ML1 channel function using ML-SIs. Notably, in experiments performed by researchers who were blind to experimental conditions, substantial FM4-64 dye uptake was seen in the presence of three structurally independent ML-SI compounds ( Fig. 3e  and Supplementary Fig. 4c) . We also used ML1 inhibitors to test the role of ML1 in sarcolemma repair in vivo. Cardiotoxin VII4 (CTX) is a toxin that can induce membrane damage in vivo to cause EB dye accumulation in muscle cells 24 . EB-positive muscle cells were more numerous in CTX-treated muscle from ML1 KO mice than in muscle from CTX-treated WT control mice ( Supplementary  Fig. 4h) . Notably, co-injection of ML-SI3 with CTX markedly increased the percentage of EB-positive muscles in CTX-treated WT mice, to the same level as in CTX-treated ML1 KO mice ( Fig. 3f  and Supplementary Fig. 4h) .
Chemical injuries from streptolysin O (SLO) toxin is often used to induce membrane repair responses, and propidium iodide (PI) staining is a common readout for membrane damage and cell viability 25 . In non-muscle cells, including mouse embryonic fibroblasts (MEFs) and bone marrow-derived macrophages (BMMs), treatment with SLO resulted in more PI-positive cells from ML1 KO mice than from WT mice ( Fig. 4a and Supplementary Fig. 5 ). In addition, ML-SI3 increased PI staining in WT, but not knockout cells (Fig. 4a and   Supplementary Fig. 5 ). Conversely, ML1 overexpression decreased PI staining (Supplementary Fig. 5 ). These results suggest that ML1 may be a core component of the membrane repair machinery in both muscle and non-muscle cells.
Membrane resealing requires the fusion and exocytosis of intracellular vesicles at sarcolemma injury sites 8 . Upon SLO treatment, pHluorin total internal reflection fluorescence (TIRF) imaging 26 showed that ML1 and Vamp7 doubly-positive vesicles underwent exocytosis ( Supplementary Fig. 6a and Supplementary Video 1) . Exocytosis of ML1-resident vesicles may lead to the appearance of ML1 proteins at the plasma membrane. Hence, measurement of whole-cell ML1 currents may provide a readout for exocytosis 14 . Consistently, SLO treatment also increased whole-cell I ML1 by two-fold to three-fold in C2C12 cells (Fig. 4b,c) . In contrast, ML-SI3−mediated inhibition of ML1, or knockout of ML1, substantially reduced SLO-induced lysosomal exocytosis as measured by Lamp1 surface staining 27 ( Supplementary Fig. 6b,c) and release of lysosomal enzymes (acid phosphatase, AP, or acid sphingomyelinase, acid SMase 28 ) (Fig. 4d,e) in muscle cells and MEFs. Collectively, these results suggest that ML1-mediated lysosomal exocytosis has an important role in membrane resealing.
Consistent with the possibility that overexpression of ML1 promotes membrane repair in mdx muscle 4, 21 , EB dye uptake and dystrophic area were both substantially less in AAV-GFP-ML1−infected muscle than in the contralateral noninjected control muscle of mdx mice (Fig. 4f,g ).
ML1 KO mice exhibit a primary early-onset MD that is caused by defective membrane resealing. A similar but less dramatic dystrophic phenotype is observed in mice lacking MG53 or dysferlin, two proteins known to be involved in membrane repair 5, 9 . By interacting with Ca 2+ sensors in the vesicles, for example, dysferlin and Syt-VII 5, 6 , ML1 may mediate membrane repair by promoting vesicle exocytosis in both muscle and non-muscle cells (Supplementary Fig. 7) . The initial rapid Ca 2+ (d) SLO (0.5 µg/ml, 1 µg/ml and 2 µg/ml for 15 min) treatment on the release of lysosomal acid phosphatase (AP; determined using an AP activity colorimetric assay kit) into the culture medium in WT and ML1 KO MEFs. The data are presented as the percentage of the activity of the released versus total cell-associated enzymes. (e) SLO (0.5 µg/mL for 15 min) treatment on the release of lysosomal acid SMase (aSMase; determined using an aSMase activity assay kit) in WT and ML1 KO MEFs. (f,g) Dystrophic area and EB uptake in gastrocnemius muscle from mdx mice after AAV-GFP-ML1 infection versus contralateral uninfected control tissue. Data are presented as the mean ± s.e.m. For panels d-g, *P < 0.05. npg l e t t e r s 1 1 9 2 VOLUME 20 | NUMBER 10 | OCTOBER 2014 nature medicine of the wound, three different mechanisms may be used for membrane repair: membrane patching, endocytosis and shedding 8, 28, 29 . Previous studies have unequivocally established the roles of extracellular Ca 2+ in all in vitro assays and models of membrane repair 5, 27, 29 . We show here that lysosomal Ca 2+ is also essential for this process, even in the presence of extracellular Ca 2+ , suggesting an involvement of more than one Ca 2+ source. Consistent with this idea, multiple Ca 2+ sensors are implicated in sarcolemma repair, including dysferlin, myoferlin, annexin, Syt-VII, Alix/ALG-2 and calcineurin 8, 29 .
Although lysosomes have long been implicated in membrane repair in non-muscle cells 27 , their role in sarcolemma repair has remained unclear. Notably, expression of the housekeeping lysosomal protein Lamp1, which is compensatorily upregulated in many LSDs, is also elevated in dysferlin-null mice 30 . In addition, mice lacking Syt-VII, a lysosome-specific Ca 2+ sensor, exhibit a MD-like phenotype 6 . Hence, the sarcolemma repair system may have a close relationship with the late endocytic pathway.
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Methods and any associated references are available in the online version of the paper. 
